Tenaya Therapeutics
Tenaya Therapeutics is a biopharmaceutical company with a mission to discover, develop, and deliver potentially curative treatments that target the underlying causes of heart disease. Tenaya is advancing multiple candidates from three product platforms - Cellular Regeneration, Gene Therapy, and Precision Medicine. Headquartered in South San Francisco, California, Tenaya was founded by world-leading scientists from the Gladstone Institute's Cardiovascular Division and from the University of Texas Southwestern Medical Center.
Last updated on
About Tenaya Therapeutics
Founded
2016Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$428MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologySIC Code
87NAICs Code
54Location
City
South San FranciscoState
CaliforniaCountry
United StatesTenaya Therapeutics
Find your buyer within Tenaya Therapeutics